142794-95-4

Basic information

• Product Name: Sodium (4R,5S,6S)-3-[[[(p-carbamoylphenyl)thio]-methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
• Synonyms: Sodium (4R,5S,6S)-3-[[[(p-carbamoylphenyl)thio]-methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
• CAS NO: 142794-95-4
• Molecular Weight: 430.481
• Mol File: 142794-95-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Sodium (4R,5S,6S)-3-[[[(p-carbamoylphenyl)thio]-methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Sodium (4R,5S,6S)-3-[[[(p-carbamoylphenyl)thio]-methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate(142794-95-4)
• EPA Substance Registry System: Sodium (4R,5S,6S)-3-[[[(p-carbamoylphenyl)thio]-methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate(142794-95-4)

Safety Data

• Hazardous Substances Data: 142794-95-4(Hazardous Substances Data)

Upstream product

• 10049-21-5 sodium dihydrogenphosphate 
• 142070-81-3 p-Nitrobenzyl (4R,5S,6S)-3-[[[(p-carbamoylphenyl)-thio]methyl]thio]-6-[1'(R)-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 
• 60-29-7 diethyl ether 

Relevant articles and documents

Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof

A dithioacetal carbapenem of the formula STR1 in which R1 is hydrogen or C1-6 alkyl; n is 0, 1 or 2; R3 is hydrogen or C1-6 alkyl; R2 is C1-6 alkyl, phenyl optionally substituted with cyano, --CO2 NH2, --CH2 OH, --CH2 NH2, --CONHNH2 or with up to 5 halogen atoms, C1-6 alkyl or C1-6 alkyloxy groups, phenylmethyl optionally substituted with up to 5 halogen atoms, C1-6 alkyl or C1-6 alkyloxy groups on the phenyl ring, or a radical represented by the formula in which p is 0 or 1; X is five-membered aromatic heterocyclic ring containing up to 1 sulfur, 1 oxygen or 4 nitrogen atoms, optionally substituted with a C1-6 alkyl group, or six-membered aromatic heterocylic ring containing up to 4 nitrogen atoms, optionally substituted with a C1-6 alkyl group. or a non-toxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate thereof.